Blenrep
- Licence status
- Active substances
- Belantamab Mafodotin
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/20/1474/001
- Licence holder
- GlaxoSmithKline (Ireland) Limited
Product documents
Licence information
- ATC code
- L01XC39 belantamab mafodotin
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription. (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 25/08/2020